MedPlus Health Services Limited (BOM:543427)

Market Cap	108.07B +9.4%
Revenue (ttm)	68.92B +12.3%
Net Income	2.20B +46.1%
EPS	18.29 +46.1%
Shares Out	n/a
PE Ratio	49.20
Forward PE	41.52
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,490
Open	866.30
Previous Close	876.00
Day's Range	866.30 - 909.20
52-Week Range	731.95 - 1,020.35
Beta	n/a
Analysts	Strong Buy
Price Target	1,163.00 (+29.14%)
Earnings Date	May 20, 2026

About MedPlus Health Services

MedPlus Health Services Limited engages in the retail trading of medicines and general items in India. It manufactures and trades in pharmaceutical and wellness products, such as prescription medicines, over-the-counter drugs, vitamins, medical devices, and diagnostic test kits; and fast-moving consumer goods (FMCG), including personal and home care products like toiletries, baby care items, soaps, detergents, and sanitizers. The company also engages in wholesale cash and carry; provision of diagnostic, pathological, and laboratory testing serv...

• Industry: Drug Stores and Proprietary Stores
• Founded: 2006
• Employees: 25,007
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 543427

Financial Performance

In fiscal year 2026, MedPlus Health Services's revenue was 68.92 billion, an increase of 12.33% compared to the previous year's 61.36 billion. Earnings were 2.20 billion, an increase of 46.12%.

Analyst Summary

According to 7 analysts, the average rating for 543427 stock is "Strong Buy." The 12-month stock price target is ₹1,163, which is an increase of 29.14% from the latest price.

Price Target

₹1,163

(29.14% upside)

Analyst Consensus: Strong Buy